Gyma

Gyma is a prominent distributor and representative of Active Pharmaceutical Ingredients (APIs) and chemical intermediates serving the generic and ethical pharmaceutical industries. Established in 1952, the company specializes in bridging the gap between global manufacturers and North American pharmaceutical firms by providing comprehensive regulatory, quality, and technical support. Gyma ensures that its sourced materials meet stringent FDA and cGMP requirements, facilitating the development and production of a wide range of medications. The company's expertise includes navigating complex regulatory filings such as Drug Master Files (DMFs) and Certificates of Suitability (CEP). In 2012, the company was acquired by Azelis, a global leader in specialty chemicals distribution, which has integrated Gyma into its Life Sciences division.